Only pharmaceutical-grade diluents, used in accordance with the relevant SmPC and under professional supervision, should ever be considered
pmc.ncbi.nlm.nih.gov/articles/PMC10338602 Zeng K, et al
If palpitations persist, ask your clinician about ambulatory monitoring, medication review, and whether dose adjustment is appropriate
Adverse Reactions/Side Effects The following important adverse reactions observed with the use of Depo-Provera CI are discussed in greater detail in the Warnings and Precautions section (5): Loss of Bone Mineral Density [see Warnings and Precautions (5.1)] Thromboembolic disease [see Warnings and Precautions (5.2)] Breast Cancer [see Warnings and Precautions (5.3)] Anaphylaxis and Anaphylactoid Reactions [see Warnings and Precautions (5.6)] Bleeding Irregularities [see Warnings and Precautions (5.11)] Weight Gain [see Warnings and Precautions (5.12)] 6.1 Clinical Trials Experience Clinical trials are conducted under widely varying conditions, therefore, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice
As a primary anti-inflammatory strategy, the evidence simply is not there yet
How much Tesofensine should I take